Advice
following a resubmission:
prucalopride (Resolor) is not recommended for use within NHS Scotland.
Indication under review: for symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief. Overall the manufacturer did not present a sufficiently robust clinical and economic analysis to gain acceptance by SMC.
The licence holder has indicated their intention to resubmit.
Download detailed advice155KB (PDF)
Medicine details
- Medicine name:
- prucalopride (Resolor)
- SMC ID:
- 653/10
- Indication:
- Chronic constipation
- Pharmaceutical company
- Shire-Movetis
- BNF chapter
- Gastro-intestinal system
- Submission type
- Resubmission
- Status
- Not recommended
- Date advice published
- 11 July 2011